Bio-Path Holdings Inc (BPTH)
2.10
+0.17
(+8.81%)
USD |
NASDAQ |
May 31, 16:00
2.10
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Accounts Payable (Quarterly): 1.746M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.746M |
December 31, 2023 | 0.457M |
September 30, 2023 | 0.277M |
June 30, 2023 | 0.638M |
March 31, 2023 | 0.827M |
December 31, 2022 | 0.667M |
September 30, 2022 | 1.046M |
June 30, 2022 | 0.611M |
March 31, 2022 | 0.409M |
December 31, 2021 | 0.106M |
September 30, 2021 | 0.417M |
June 30, 2021 | 0.507M |
March 31, 2021 | 0.394M |
December 31, 2020 | 0.10M |
September 30, 2020 | 0.614M |
June 30, 2020 | 0.726M |
March 31, 2020 | 0.818M |
December 31, 2019 | 0.486M |
September 30, 2019 | 0.522M |
June 30, 2019 | 0.444M |
March 31, 2019 | 0.607M |
December 31, 2018 | 0.587M |
September 30, 2018 | 0.451M |
June 30, 2018 | 0.137M |
March 31, 2018 | 0.136M |
Date | Value |
---|---|
December 31, 2017 | 0.052M |
September 30, 2017 | 0.121M |
June 30, 2017 | 0.096M |
March 31, 2017 | 0.089M |
December 31, 2016 | 0.069M |
September 30, 2016 | 0.118M |
June 30, 2016 | 0.123M |
March 31, 2016 | 0.201M |
December 31, 2015 | 0.054M |
September 30, 2015 | 0.1271M |
June 30, 2015 | 0.3851M |
March 31, 2015 | 0.0766M |
December 31, 2014 | 0.041M |
September 30, 2014 | 0.0885M |
June 30, 2014 | 0.0789M |
March 31, 2014 | 0.238M |
December 31, 2013 | 0.0761M |
September 30, 2013 | 0.0436M |
June 30, 2013 | 0.1759M |
March 31, 2013 | 0.0719M |
December 31, 2012 | 0.0656M |
September 30, 2012 | 0.0654M |
June 30, 2012 | 0.0537M |
March 31, 2012 | 0.0584M |
December 31, 2011 | 0.1895M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.10M
Minimum
Dec 2020
1.746M
Maximum
Mar 2024
0.5906M
Average
0.5145M
Median
Accounts Payable (Quarterly) Benchmarks
INVO Bioscience Inc | -- |
Perspective Therapeutics Inc | 6.027M |
EyePoint Pharmaceuticals Inc | 7.082M |
Palatin Technologies Inc | 3.443M |
Lumos Pharma Inc | 0.569M |